Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Postpartum Hemorrhage After Cesarean Delivery in Women With Systemic Autoimmune Disease: A Multicenter Retrospective Study

NCT06730919 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06730919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06730919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Postpartum Hemorrhage After Cesarean Delivery in Women With Systemic Autoimmune Disease: A Multicenter Retrospective Study
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
December 30, 2024
Enrollment
1,000 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage, systemic autoimmune diseases